可除颤心律院外心脏骤停的靶向温度管理:冠状动脉造影后心脏骤停试验的事后分析
90天生存率两组无显著差异(63.6% vs 67.9%;HR 0.86,95%CI 0.62-1.18;P=0.35;校正OR 0.89,95%CI 0.45-1.72)。低温组ICU停留时间更长(4天 vs 3天;几何均数比1.32,95%CI 1.15-1.51),血压更低、乳酸更高、需要正性肌力支持更多。90天神经功能结局及1年患者报告心理健康与身体健康评分两组相似。
要点
- 可除颤心律且无ST段抬高的院外心脏骤停患者中,轻度治疗性低温(32.0-34.0°C)与靶向常温(36.0-37.0°C)90天生存率无差异(63.6% vs 67.9%;HR 0.86,95%CI 0.62-1.18;P=0.35)。
- 校正后90天生存的OR为0.89(95%CI 0.45-1.72),低温未显示生存获益。
- 低温组ICU停留时间更长(4天[3-7] vs 3天[2-5];几何均数比1.32,95%CI 1.15-1.51),且血压更低、乳酸更高、正性肌力支持需求增加。
- 90天脑功能分类(CPC)评分及1年患者报告心理健康与身体健康评分两组相似。
- 温度策略由医生决定,非随机分配,结果需谨慎解读。
适用人群与场景
- 成功复苏的院外心脏骤停患者,初始心律为可除颤心律,且心电图无ST段抬高。
- 温度管理策略由医生决定,非随机分配。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 干预与对照:轻度治疗性低温(32.0-34.0°C)vs 靶向常温(36.0-37.0°C),分配由医生决定。
- 主要终点:90天生存率低温组63.6%(171例)vs 常温组67.9%(129例);HR 0.86(95%CI 0.62-1.18);log-rank P=0.35;校正OR 0.89(95%CI 0.45-1.72)。
- 关键次要终点:低温组ICU停留时间更长(4天[3-7] vs 3天[2-5];几何均数比1.32,95%CI 1.15-1.51);低温组血压更低、乳酸更高、正性肌力支持需求增加。
- 神经功能结局:ICU出院时和90天随访的脑功能分类(CPC)评分两组相似;1年患者报告心理健康与身体健康评分两组相似。
证据类型、等级与局限
- 证据类型:随机对照试验(CORONARY试验)的观察性事后亚组分析。
- 局限:温度管理策略非随机分配(由医生决定),为观察性亚组分析,可能存在选择偏倚和混杂;原文未提及证据等级或推荐强度。
对床旁实践的改变
- 对于可除颤心律且无ST段抬高的院外心脏骤停患者,轻度治疗性低温(32.0-34.0°C)与靶向常温(36.0-37.0°C)相比未改善90天生存率,且低温组ICU停留时间更长、血流动力学更差(血压更低、乳酸更高、正性肌力支持更多)。
- 该结果来自非随机分配的观察性亚组分析,不能作为改变常规实践的确定性依据,温度策略选择仍需结合个体情况。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The optimal targeted temperature in patients with shockable rhythm is unclear, and current guidelines recommend targeted temperature management with a correspondingly wide range between 32°C and 36°C. Our aim was to study survival and neurologic outcome associated with targeted temperature management strategy in postarrest patients with initial shockable rhythm.
DESIGN: Observational substudy of the Coronary Angiography after Cardiac Arrest without ST-segment Elevation trial.
SETTING: Nineteen hospitals in The Netherlands.
PATIENTS: The Coronary Angiography after Cardiac Arrest trial randomized successfully resuscitated patients with shockable rhythm and absence of ST-segment elevation to a strategy of immediate or delayed coronary angiography. In this substudy, 459 patients treated with mild therapeutic hypothermia (32.0-34.0°C) or targeted normothermia (36.0-37.0°C) were included. Allocation to targeted temperature management strategy was at the discretion of the physician.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: After 90 days, 171 patients (63.6%) in the mild therapeutic hypothermia group and 129 (67.9%) in the targeted normothermia group were alive (hazard ratio, 0.86 [95% CI, 0.62-1.18]; log-rank p = 0.35; adjusted odds ratio, 0.89; 95% CI, 0.45-1.72). Patients in the mild therapeutic hypothermia group had longer ICU stay (4 d [3-7 d] vs 3 d [2-5 d]; ratio of geometric means, 1.32; 95% CI, 1.15-1.51), lower blood pressures, higher lactate levels, and increased need for inotropic support. Cerebral Performance Category scores at ICU discharge and 90-day follow-up and patient-reported Mental and Physical Health Scores at 1 year were similar in the two groups.
CONCLUSIONS: In the context of out-of-hospital cardiac arrest with shockable rhythm and no ST-elevation, treatment with mild therapeutic hypothermia was not associated with improved 90-day survival compared with targeted normothermia. Neurologic outcomes at 90 days as well as patient-reported Mental and Physical Health Scores at 1 year did not differ between the groups.
参考来源
- Spoormans EM, Lemkes JS, Janssens GN, et al. Targeted Temperature Management in Out-of-Hospital Cardiac Arrest With Shockable Rhythm: A Post Hoc Analysis of the Coronary Angiography After Cardiac Arrest Trial. Crit Care Med. 2022. PMID: 34637414. doi:10.1097/CCM.0000000000005271
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。